Document is current
Any future updates will be listed below
-
Authors
Rappold, Ronja
Kalogeropoulos, Konstantinos
La Regina, Gianna
auf dem Keller, Ulrich
Slack, Emma
Vogel, Viola
-
Funding
Funding for this research was provided by:
EMBO Scintific Exchange Grant (9683)
Botnar Research Centre for Child Health, University of Basel (Multi-Investigator Project 2020)
Botnar Research Centre for Child Health, University of Basel (Multi-Investigator Project 2020)
Botnar Research Centre for Child Health, University of Basel (Multi-Investigator Project 2020)
Botnar Research Centre for Child Health, University of Basel (Multi-Investigator Project 2020)
PRO-MS: Danish National Mass Spectrometry Platform for Functional Proteomics (5072-00007B)
PRO-MS: Danish National Mass Spectrometry Platform for Functional Proteomics (5072-00007B)
Novo Nordisk Foundation Young Investigator Award (NNF16OC0020670)
Novo Nordisk Foundation Young Investigator Award (NNF16OC0020670)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_185128, 40B2-0_180953, 310030_204345)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_185128, 40B2-0_180953, 310030_204345)
European Research Council Consolidator Grant (865730-SNUGly)
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 13 September 2024
First Online: 4 February 2025
Competing interests
: V.V. is cofounder and scientific advisory board member of Tandem Therapeutics AG (CHE-192.070.977), an early-state start-up developing extracellular matrix targeting drugs during fibrotic diseases. All other authors declare no conflict of interest.
